Skip to main content
Premium Trial:

Request an Annual Quote

Benjamin Salisbury

GenomOncology has appointed Benjamin Salisbury as vice president of new products and marketing. He will be responsible for the company's corporate marketing and for bringing to market new products that build upon the company's precision medicine technology. Salisbury joins the company from Knome, where he guided the transition of the company's research-focused, internal-use software for next-generation sequencing analysis to a product that supports clinical laboratory operations. He has also held several management and scientific positions at Transgenomic, PGxHealth, and Genaissance Pharamaceuticals. As a scientist, Salisbury's expertise includes molecular diagnostics, pharmacogenomics, population genetics, statistical genetics, and algorithm development. He has authored over 30 peer-reviewed publications in these and other fields. 

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.